PHARMA & HEALTHCARE

Pharma & Healthcare

Latest Reports

Depression Drugs Market with (Covid-19) Impact Analysis (By Type: Tricyclice Antidepressants, Serotonin-Norepinephrine Inhibitors, Others; By Application: Clinics and Hospitals; By Geography: North America, Europe, Asia Pacific, RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2027

Global Depression Drug Market is forecasted to reach $18 billion by 2024; growing at a CAGR of 2.6% from 2016 to 2024. Depression has occurred as one of the most common yet serious mental disorders among people globally. Depression is caused by amalgamation of genetics, biological, environment and p...

Read More

Membrane Technology in Pharma, Biopharma, And Life Science Market with (Covid-19) Impact Analysis (By Application: Pharmaceuticals, Biopharmaceuticals, And Life Sciences; By Technology: Ultrafiltration, Microfiltration, Nanofiltration, Chromatography; North America, Europe, Asia-Pacific, and RoW) Global Scenario, Market Size, Outlook, Trend, and Forecast, 2015-2027

Global Membrane Technology in Pharma, Biopharma, and Life Science Market is estimated to reach $16,375 million by 2024; growing at a CAGR of 9.3% from 2016 to 2024. Membrane technology is a separation process by using specific semi-permeable membrane filters to fractionate or concentrate a liquid co...

Read More

Cleanroom Technology Market with (Covid-19) Impact Analysis (By Type: Equipment And Consumables; By Construction: Standard/Drywall Cleanrooms, Hardwall Cleanrooms, Softwall Cleanrooms And Terminal Boxes/Pass Through Cabinets; By Application: Biotechnology, Pharmaceuticals, Medical Devices And Others; By Geography: North America, Europe, Asia-Pacific and RoW) Global Scenario, Market Size, Outlook, Trend, and Forecast, 2015-2027

Global Cleanroom Technology Market is estimated to reach $5,171 million by 2024, growing at a CAGR of 5.1% from 2016 to 2024. Cleanroom technology offers safe & hygienic atmosphere to research institutes, hospitals, manufacturers, pharmaceuticals, and others. This technology provide protection to ro...

Read More

Diabetic Nephropathy Market with (Covid-19) Impact Analysis (By Mode of Treatment: Drug Modifying Therapies, and Others; By Geography: North America, Europe, Asia-Pacific and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2027

Global Diabetic Nephropathy Market is estimated to reach $3,826 million by 2024; growing at a CAGR of 5.9% from 2016 to 2024. Diabetic nephropathy involves damage of kidney due to the presence of diabetic mellitus. It is a progressive kidney disease majorly caused due to occurrence if persistent pro...

Read More

Biological Drugs Market with (Covid-19) Impact Analysis (By Product Type: Therapeutic Protein, Monoclonal Antibody, and Vaccine; By Geography: North America, Europe, Asia-Pacific, and RoW) Global Scenario, Market Size, Outlook, Trend, and Forecast, 2015-2027

Global Biological Drugs Market is estimated to reach $394 billion by 2024; growing at a CAGR of 10.3% from 2016 to 2024. Biological drugs are products manufactured by using microorganisms or plants or animal cells and are used for prevention, diagnosis and treatment of several diseases. These drugs ...

Read More

Treatment for Syndromes of Dementia and Movement Disorders Market with (Covid-19) Impact Analysis (By Type: Movement Disorders, Progressive Dementia, and Progressive Dementia with Neurological Abnormalities; By Geography: North America, Europe, Asia-Pacific and RoW) Global Scenario, Market Size, Outlook, Trend, and Forecast, 2015-2027

Global Treatment for Syndromes of Dementia and Movement Disorders Market is estimated to reach $28.6 Billion by 2024; growing at a CAGR of 8.9% from 2016 to 2024. Dementia is loss of thinking capability or a collection of symptoms caused by disorders affecting brain. Dementia and movement disorders ...

Read More

E-Clinical Solution Software Market with (Covid-19) Impact Analysis (Clinical Data Management, Clinical Trial Management System, Electronics Clinical Outcome Assessment Solution; Web Based E-Clinical Solution Software, Enterprise Licensed, And Cloud Based E-Clinical Solution Software; Pharmaceuticals, Healthcare Providers; North America, Europe, Asia-Pacific) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2027

Global E-Clinical Solution Software Market is estimated to reach $10.6 billion by 2024; growing at a CAGR of 13.4% from 2016 to 2024. E-clinical solution is software that is used for automating the management of clinical trials. It is capable of replacing manually-driven methods. This technology aid...

Read More

Biopharmaceuticals Market with (Covid-19) Impact Analysis (Monoclonal Antibodies, Recombinant Proteins, Granulocyte Colony-Stimulating Factor, Interferon, Recombinant Human Insulin, Erythropoietin, Vaccines, Growth Hormones, Purified Proteins; Oncology, Inflammatory Infectious Diseases, Metabolic Disorders, Cardiovascular Diseases; North America, Europe, Asia-Pacific, and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2027

Global Biopharmaceuticals Market is estimated to reach $405 billion by 2024; growing at a CAGR of 9.3% from 2016 to 2024. Biopharmaceuticals are proteins and nucleic acids that are produced by means of recombinant DNA techniques, purification processes, and hybridoma techniques. The production of th...

Read More

Uveitis Treatment Market with (Covid-19) Impact Analysis (By Type: Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, And Panuveitis; By Treatment Type: Anti-Inflammatory Medications, Antibiotic/Antiviral Medications, And Immunosuppressive Medications; By Geography: North America, Europe, Asia-Pacific, and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2027

Global Uveitis Treatment Market is estimated to reach $1,142 million by 2024; growing at a CAGR of 7.5% from 2016 to 2024. Uveitis is a type of inflammatory disease that induces swelling and destroys eye tissues of one or both eyes. The primary causes of uveitis include toxins that penetrate the eye...

Read More

Sleeping Aids Market with (Covid-19) Impact Analysis (By Product Type: Mattresses and Pillows, Sleep Laboratories, Medication, Sleep Apnea Devices; By Sleep Disorder: Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Sleep Walking; By Geography: North America, Europe, Asia-Pacific and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2027

Global Sleeping Aids Market is estimated to reach $96 billion by 2024; growing at a CAGR of 6.3 % from 2016 to 2024. Sleeping aids are drugs and medical devices used to identify and treat different sleeping disorders. Sleep apnea, insomnia, daytime sleepiness are indications of sleep disorder. Human...

Read More
View all